Ozempic isn’t the only drug that mimics the natural GLP-1 hormone, so users feel fuller for longer and eat less. There’s also Zepbound, Mounjaro, Trulicity and Victoza — and many more on the horizon ...

Cosby received these refills a total of 7 times at a poker game and says that he never took one himself. Dr. Leroy Amar ...

New vaccines are helping Ghana approach a long-sought goal of ending child deaths from malaria, demonstrating the potential of the shots to drive back a disease that kills nearly half a million young ...

Overview of the African Pharmaceutical MarketThe African pharmaceutical market is projected to grow at a compound annual rate ...

(THE CONVERSATION) Every year, malaria kills more than 600,000 people worldwide. Most of them are children under 5 in sub-Saharan Africa. But the disease isn’t confined to poor, rural areas – it’s a ...

Partnership adds a travel-focused consumer telehealth platform to the ARAKODA® marketing strategy, offering a new convenience ...

From effective outbreak control to promising new research, a few developments that suggest key parts of the global health system are still functioning well, even under strain. Get the latest in the ...

Please provide your email address to receive an email when new articles are posted on . There were 282 million malaria cases reported globally in 2024. WHO’s 2025 malaria report links antimalarial ...

A child is vaccinated against malaria on September 13, 2019 in Ndhiwa, Homabaya County, Western Kenya during the launch of a malaria vaccine in Kenya. The vaccine (Mosquirix) is the world's first ...

The first new malaria treatment in decades holds promise against rising drug resistance after Swiss drugmaker Novartis announced it was as effective at treating the disease as established treatments.

Researchers on Wednesday reported two promising new approaches to counteract malaria's growing resistance to medication -- one involving a new class of drugs. Switzerland-based Novartis released ...